Trademark: 75372071
Status Date
Friday, October 29, 2021
Registration Number
2287056
Registration Date
Tuesday, October 19, 1999
Filing Date
Tuesday, October 14, 1997
Published for Opposition
Tuesday, July 27, 1999
Cancellation Date
Friday, October 29, 2021
1 packaging cell line that produces retroviral gene therapy vectors for medical research and pharmaceutical research and development
5 packaging cell line that produces retroviral gene therapy vectors for the treatment of [ cancer, AIDS, metabolic diseases, neurogenerative diseases, cardiovascular diseases, ] hemoglobinopathies [ and hormone deficiencies ]
The mark consists of a stylized viral particle.
Oct 29, 2021
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Oct 19, 2018
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Dec 11, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 11, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2017
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 6, 2017
Teas Change Of Owner Address Received
Mar 28, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 28, 2012
Automatic Update Of Assignment Of Ownership
Oct 24, 2009
Registered And Renewed (First Renewal - 10 Yrs)
Oct 24, 2009
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Oct 19, 2009
Teas Section 8 & 9 Received
Jan 16, 2009
Notice Of Design Search Code Mailed
Sep 5, 2006
Case File In Ticrs
Jul 8, 2006
Registered - Sec. 8 (6-Yr) Accepted
Apr 14, 2006
Registered - Sec. 8 (6-Yr) Filed
Apr 14, 2006
Teas Section 8 Received
Oct 19, 1999
Registered-Principal Register
Jul 27, 1999
Published For Opposition
Jun 25, 1999
Notice Of Publication
Apr 9, 1999
Approved For Pub - Principal Register
Jan 27, 1999
Non-Final Action Mailed
Dec 21, 1998
Correspondence Received In Law Office
Jun 18, 1998
Non-Final Action Mailed
Jun 3, 1998
Assigned To Examiner
Jun 2, 1998
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
